Revenue
2022
2023
2024
2025
Molecule Group plc (MOL)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| Operating expenses | £1.3M | £25,342 | £74,506 | £22,991 |
| Operating income | −£1.3M | −£25,342 | −£74,506 | −£22,991 |
| EBITDA | −£1.3M | −£25,342 | −£74,506 | −£22,991 |
| Net income | −£1.2M | −£25,342 | −£74,533 | −£22,702 |
| Basic EPSper basic share | -£0.45 | -£0.00 | -£0.01 | -£0.00 |
| Diluted EPSper diluted share | -£0.45 | -£0.00 | -£0.01 | -£0.00 |
Owners
Reported major voting-rights holders
16.60%of voting rights
Octopus Investments LimitedNotified Jul 16, 2026
View holders
| Holder | Voting rights |
|---|---|
| 16.60%Jul 16, 2026 · 4.53M votes | |
| 15.95%Sep 3, 2026 · 4.35M votes | |
| 4.46%Mar 27, 2026 · 1.22M votes | |
| 4.40%Mar 19, 2026 · 1.2M votes | |
| 3.05%Aug 28, 2026 · 831.57K votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: FCA voting-rights notice ↗Updated Oct 21, 2026